Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT)

Journal of Visualized Experiments

Volumn , Issue 63, 2012, Pages

  Mehta, Nehal N ^a   Torigian, Drew A ^a   Gelfand, Joel M ^a   Saboury, Babak ^a   Alavi, Abass ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Atherosclerosis; FDG PET CT; Imaging; Issue 63; Medicine; Quantitative radiology; Vascular inflammation

Indexed keywords

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD; COMPUTER ASSISTED TOMOGRAPHY; GLUCOSE BLOOD LEVEL; HUMAN; INSTRUMENTATION; METABOLISM; METHODOLOGY; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING;

BLOOD GLUCOSE; FLUORODEOXYGLUCOSE F18; HUMANS; PLAQUE, ATHEROSCLEROTIC; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84863732126     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/3777     Document Type: Article

References (28)

1. Church, T.S., et al. Coronary artery calcium score, risk factors, and incident coronary heart disease events. Atherosclerosis. 190, 224-231 (2007).
2. Kathiresan, S., et al. Assessment by cardiovascular magnetic resonance, electron beam computed tomography, and carotid ultrasonography of the distribution of subclinical atherosclerosis across Framingham risk strata. Am. J. Cardiol. 99, 310-314, (2007).
3. Detrano, R., et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N. Engl. J. Med. 358, 1336-1345 (2008).
4. Raggi, P., Cooil, B., Ratti, C., Callister, T.Q., & Budoff, M. Progression of Coronary Artery Calcium and Occurrence of Myocardial Infarction in Patients With and Without Diabetes Mellitus. Hypertension., (2005).
5. Arad, Y., Goodman, K.J., Roth, M., Newstein, D., & Guerci, A.D. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. J. Am. Coll. Cardiol. 46, 158-165 (2005).
6. Lorenz, M.W., Markus, H.S., Bots, M.L., Rosvall, M., & Sitzer, M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 115, 459-467 (2007).
7. Doherty, T.M., Detrano, R.C., Mautner, S.L., Mautner, G.C., & Shavelle, R.M. Coronary calcium: the good, the bad, and the uncertain. Am. Heart. J. 137, 806-814 (1999).
8. Detrano, R. C.,et al. Coronary calcium does not accurately predict near-term future coronary events in high-risk adults. Circulation. 99, 2633-2638 (1999).
9. Chen, W., Bural, G.G., Torigian, D.A., Rader, D.J., & Alavi, A. Emerging role of FDG-PET/CT in assessing atherosclerosis in large arteries. Eur. J. Nucl. Med. Mol. Imaging. 36, 144-151, doi:10.1007/s00259-008-0947-2 (2009).
10. Doherty, T.M., et al. Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads. Proc. Natl. Acad. Sci. U.S.A. 100, 11201-11206 (2003).
11. Fuster, V. & Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation. 90, 2126-2146 (1994).
12. van der Wal, A.C., Becker, A.E., van der Loos, C.M., & Das, P.K. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 89, 36-44 (1994).
13. van der Wal, A.C., Becker, A.E., van der Loos, C.M., Tigges, A.J., & Das, P.K. Fibrous and lipid-rich atherosclerotic plaques are part of interchangeable morphologies related to inflammation: a concept. Coron. Artery Dis. 5, 463-469 (1994).
14. Alavi, A., et al. Positron emission tomography imaging of regional cerebral glucose metabolism. Semin. Nucl. Med. 16, 2-34 (1986).
15. Hustinx, R., et al. Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck. Eur. J. Nucl. Med. 26, 1345-1348 (1999).
16. Ogawa, M., et al. (18)F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. J. Nucl. Med. 45, 1245-1250 (2004).
17. Yun, M., et al. F-18 FDG uptake in the large arteries: a new observation. Clin. Nucl. Med. 26, 314-319 (2001).
18. Mehta, N.N., et al. Systemic and Vascular Inflammation in Patients With Moderate to Severe Psoriasis as Measured by [18F]-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (FDG-PET/CT): A Pilot Study. Arch. Dermatol. doi:10.1001/archdermatol.2011.119 (2011).
19. Davies, J.R., et al. FDG-PET can distinguish inflamed from non-inflamed plaque in an animal model of atherosclerosis. Int. J. Cardiovasc. Imaging. 26, 41-48, doi:10.1007/s10554-009-9506-6 (2011).
20. Bural, G.G., et al. FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries. Eur. J. Nucl. Med. Mol. Imaging. 35, 562-569, doi:10.1007/s00259-007-0528-9 (2008).
21. Arauz, A., Hoyos, L., Zenteno, M., Mendoza, R., & Alexanderson, E. Carotid plaque inflammation detected by 18F-fluorodeoxyglucose-positron emission tomography. Pilot study. Clin. Neurol. Neurosurg. 109, 409-412 (2007).
22. Rominger, A., et al. 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease. J. Nucl. Med. 50, 1611-1620 (2009).
23. Wasselius, J.A., Larsson, S.A., & Jacobsson, H. FDG-accumulating atherosclerotic plaques identified with 18F-FDG-PET/CT in 141 patients. Mol. Imaging Biol. 11, 455-459, doi:10.1007/s11307-009-0223-2 (2009).
24. Tahara, N., et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J. Am. Coll. Cardiol. 48, 1825-1831 (2006).
25. Lee, S.J., et al. Reversal of vascular 18F-FDG uptake with plasma high-density lipoprotein elevation by atherogenic risk reduction. J. Nucl. Med. 49, 1277-1282 (2008).
26. Rudd, J.H., et al. (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J. Am. Coll. Cardiol. 50, 892-896 (2007).
27. Bural, G.G., et al. A pilot study of changes in (18)F-FDG uptake, calcification and global metabolic activity of the aorta with aging. Hell. J. Nucl. Med. 12, 123-128 (2009).
28. Bural, G.G., et al. Quantitative assessment of the atherosclerotic burden of the aorta by combined FDG-PET and CT image analysis: a new concept. Nucl. Med. Biol. 33, 1037-1043 (2006).